Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs） | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）	Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, diffuse scleroderma, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, scleroderma, skin disorder, systemic lupus erythematosus, systemic sclerosis	Recruiting	Phase 1	2026-08-12		NCT06801119

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shenzhen MagicRNA Biotechnology Co., Ltd	4
The First Affiliated Hospital of University of Science and Technology of China	31

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of University of Science and Technology of China	Hefei	China	16